Strategy

Vectura's goal is to be a cash-generating business that creates value for its stakeholders. To achieve this goal, Vectura is:

Developing pulmonary products using its proprietary inhaler device and formulation technologies, significant expertise and know-how to proof-of-concept
- for selected products Vectura plans to further develop/co-develop in-house to regulatory approval in order to capture maximum value for the Company and its shareholders
- for the products that address larger markets, Vectura will out-license the products to major pharmaceutical companies that have appropriate financial resources and existing sales and marketing infrastructures (Vectura’s return being milestones and royalties)
Entering into technology collaborations with pharmaceutical company partners to exploit both the generic and branded markets for the joint development of high-value pulmonary product opportunities, and
Continuing to build its pulmonary franchise through internal innovation as well as exploring opportunities for the acquisition of products, technologies or businesses that support these goals.